Ennature Bio Pharma Limited share price & analysis

NSE: ENNATURE · Healthcare · as of 06 Nov 2026

₹227.20-5.00%

Market cap—

P/E—

Industry P/E46.7

P/B—

ROE—

Debt / equity—

Dividend yield—

EPS (TTM)—

52W high₹251.70

52W low₹227.20

Net margin—

Operating margin—

Returns

1 month—

6 months—

1 year—

3Y CAGR—

5Y CAGR—

10Y CAGR—

From 52W high-9.7%

Technical indicators

50-day avg—

200-day avg—

RSI (14)—

Avg volume (20D)54,186

StoxGud checklist: Bearish setup · 0/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

About Ennature Bio Pharma Limited stock

Ennature Bio Pharma Limited (ENNATURE) shares closed at ₹227.20 on 06 Nov 2026, down 5.00% on the day. On StoxGud's 10-point checklist it scores 0/10, a bearish setup.

Healthcare peers

Company	Price	Market cap	P/E	1Y
Sun Pharmaceutical Industries Ltd.	₹1,860.00	₹4,46,270 Cr	40.7	+8.4%
Divi's Laboratories Ltd.	₹10,320.50	₹2,73,493 Cr	93.5	+58.5%
Torrent Pharmaceuticals Ltd.	₹4,750.00	₹1,80,671 Cr	85.1	+32.0%
Laurus Labs Ltd.	₹2,340.00	₹1,26,430 Cr	94.4	+143.3%
Apollo Hospitals Enterprise Ltd.	₹8,446.00	₹1,21,453 Cr	54.2	+7.5%
Zydus Lifesciences Ltd.	₹1,197.90	₹1,19,550 Cr	28.6	+19.4%

FAQs

What is the share price of Ennature Bio Pharma Limited?

Ennature Bio Pharma Limited (ENNATURE) closed at ₹227.20 on NSE on 06 Nov 2026.

What is the 52-week high and low of Ennature Bio Pharma Limited?

The 52-week high is ₹251.70 and the 52-week low is ₹227.20.